Successful tocilizumab-based combination therapy for a case of rapidly progressive adult deep morphea with multiple antiphospholipid antibodies: a case report and literature review

BackgroundLocalized Scleroderma (LoS), particularly aggressive subtypes such as Deep Morphea (morphea profunda), is a rare chronic autoimmune fibrosing disorder that can extend into the subcutaneous tissue, fascia, and muscle. These deep forms carry a high risk of functional impairment. Tocilizumab...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ruohan Yu, Lina Zhang, Sheng-Guang Li, Jing Zhang, Ji Li, Yadan Zou, Ting Long, Yanfeng Zhang, Guanjun Yue
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-02-01
coleção:	Frontiers in Immunology
Assuntos:	antiphospholipid antibodies case report deep morphea interleukin-6 (IL-6) localized scleroderma tocilizumab
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1764835/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!